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The complexes of the electron transport chain asso-
ciate into large macromolecular assemblies, which
are believed to facilitate efficient electron flow. We
have identified a conserved mitochondrial protein,
named respiratory supercomplex factor 1 (Rcf1—
Yml030w), that is required for the normal assembly
of respiratory supercomplexes. We demonstrate
that Rcf1 stably and independently associates with
both Complex III and Complex IV of the electron
transport chain. Deletion of the RCF1 gene caused
impaired respiration, probably as a result of destabi-
lization of respiratory supercomplexes. Consistent
with the hypothetical function of these respiratory
assemblies, loss ofRCF1 caused elevatedmitochon-
drial oxidative stress and damage. Finally, we show
that knockdown of HIG2A, a mammalian homolog
of RCF1, causes impaired supercomplex formation.
We suggest that Rcf1 is a member of an evolution-
arily conserved protein family that acts to promote
respiratory supercomplex assembly and activity.
INTRODUCTION
Mitochondria are unique and complex organelles that perform
essential functions in many aspects of cell biology. It is not
surprising, therefore, that mitochondrial dysfunction is associ-
ated with many forms of human disease. This includes relatively
common disorders, such as cancer (Kroemer and Pouyssegur,
2008), diabetes (Patti and Corvera, 2010), and neurodegenera-
tive disease (Lessing and Bonini, 2009). Beyond these common
disorders, which are all age-related, mitochondrial dysfunction
has been associated with the aging process itself. Manipulation
of mitochondrial function, including by modulation of mitochon-
drial oxidative stress andmitochondrial DNA (mtDNA) mutability,
has striking effects on longevity (Schriner et al., 2005; Trifunovic
et al., 2004).
The intimate connection between oxidative stress, mitochon-
drial dysfunction, and age-related disorders is thought to derive
from the physical proximity of the electron transport chain (ETC)348 Cell Metabolism 15, 348–360, March 7, 2012 ª2012 Elsevier Inc.and the mtDNA. The ETC is the major source of reactive oxygen
species (ROS) in most cells. This ROS load is then in immediate
proximity to the mtDNA, which is highly sensitive to mutagenic
insult. Mutated mtDNA is then postulated to be a causal factor
in further ETC dysfunction, leading to a vicious cycle of ROS
production (Wallace, 2005). The challenge for the ETC is to
conduct reactive electrons via soluble carriers, through three
distinct multiprotein complexes, to oxygen. When this conduc-
tion process is disturbed, the risk of ROS production increases.
Because this oxidative stress/ETC/aging axis is of such rele-
vance to human disease, it is of great importance to understand
the mechanisms that have evolved to prevent inappropriate
ROS production. One biochemical phenomenon that has been
postulated to control ETC malfunction and prevent mitochon-
drial ROS production is the assembly of the individual ETC
complexes into massive conduction machines called respiratory
supercomplexes (Cruciat et al., 2000; Lenaz and Genova, 2009).
The clear importance of mitochondria has led to extensive
efforts to define the mitochondrial proteome in many species.
The best current inventory of mammalian mitochondrial-resident
proteins consists of 1,098 proteins (Pagliarini et al., 2008).
Surprisingly, nearly 300 of these proteins are largely or com-
pletely unstudied (Pagliarini et al., 2008). Included among this
number are many that are conserved throughout the eukaryotic
kingdom. Such conservation implies that they perform a function
that is of fundamental importance for cell viability. As a result, we
initiated a project to identify the functions of a subset of these
highly and evolutionarily conserved but uncharacterized mito-
chondrial proteins. We previously described the function of
SDH5/SDHAF2, which is required for assembly of ETC Complex
II and is mutated in multiple families afflicted with the paragan-
glioma tumor syndrome (Bayley et al., 2010; Hao et al., 2009).
We also described Vms1, which plays an important role in
stress-responsive recruitment of the ubiquitin-proteasome
machinery to mitochondria for protein degradation (Heo et al.,
2010).
Herein, we describe the function of Rcf1, which we show is
a stable component of ETC supercomplexes and is required
for their normal stability. In Saccharomyces cerevisiae, ETC
supercomplexes are assemblies in the mitochondrial inner
membrane that contain, among other proteins, both cytochrome
bc1 complex (Complex III) and cytochrome c oxidase complex
(Complex IV) and perhaps Complex II as well (Stuart, 2008).
In mammals, supercomplexes often also contain Complex I
Figure 1. Rcf1 Is a Mitochondrial Inner
Membrane Protein Important for Respira-
tion
(A) The rcf1D mutant expressing Rcf1-GFP and
MtRFP grown to log phase in SD medium was
imaged by fluorescence microscopy.
(B) Intact mitochondria, hypotonic-swollen mito-
plasts, and Triton X-100–solubilized mitochondria
of a strain expressing Rcf1-His6/HA3 were treated
either with (+) or without () Proteinase K and
analyzed by immunoblot with the whole-cell lysate
(WCL) and postmitochondrial supernatant
(PMS). Cox2, Mge1, Cyb2, and Fzo1 are inner
membrane, matrix, intermembrane space, and
outer membrane proteins, respectively.
(C) Soluble (S) and pellet (P) fractions from alkali
and high-salt extracted mitochondria expressing
Rcf1-His6/HA3 were analyzed by immunoblot.
Cyb2 is a soluble intermembrane space protein;
Cox4 is an inner membrane-associated protein;
Cox2 is an integral inner membrane protein; and
Por1 is an integral outer membrane protein.
(D) Five-fold serial dilutions of the indicated strains
harboring an empty vector (EV) or a plasmid ex-
pressing Rcf1-His6/HA3 were spotted on plates
and incubated at 30C and 37C.
(E) WT and rcf1D mutant strains of the BY4741
background were grown in glucose, lactate, or
glycerol to log phase and the rate of oxygen con-
sumption was measured. Data shown is repre-
sentative of three independent experiments and
mean + SD is shown. *p < 0.05; **p < 0.01.
See also Figure S1.
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macromolecular assemblies are believed to enable more effi-
cient electron flow between complexes and to promote complex
stability (Suthammarak et al., 2010). This efficiency is believed to
reduce electron loss from ETC and ROS generation (Genova
et al., 2008). Not surprisingly, we show that the rcf1D mutant,
which exhibits decreased supercomplex assembly, has
increased mitochondrial oxidative damage. We also show that
knockdown of HIG2A, one of the mammalian orthologs of
RCF1, impairs supercomplex assembly in mouse cells. We,
therefore, speculate that the RCF1 gene family plays an evolu-
tionarily conserved role in maintaining mitochondrial function
through the optimal assembly of electron transport chainCell Metabolism 15, 348–3complexes. Thereby, it might be a
component of the cellular system to
delay ROS-induced and age-associated
degeneration.
RESULTS
Rcf1 Is an Integral Mitochondrial
Inner Membrane Protein Required
for Normal Respiration
Using the yeast S. cerevisiae as the
primary model system, we first verified
mitochondrial localization of the Rcf1
(Yml030w/Aim31) protein using twocomplementary methods. First, we generated a strain express-
ing an Rcf1-GFP fusion protein from the native promoter, which
is fully functional as assessed by suppression of the rcf1D
phenotype (data not shown). This strain was cotransformed
with a plasmid expressing a mitochondria-targeted red fluores-
cent protein (MtRFP). As seen in Figure 1A, we observed
complete overlap between the mitochondrial RFP signal and
the Rcf1-GFP signal. Under no conditions did we find extramito-
chondrial GFP fluorescence.
In parallel, we also biochemically examined the localization of
an Rcf1 fusion protein with a dual His6/HA3-tag at its C terminus.
This fusion protein, which is expressed from the native promoter,
was also demonstrated to be fully functional (see Figure 1D).60, March 7, 2012 ª2012 Elsevier Inc. 349
Figure 2. Rcf1 Physically Interacts with Respira-
tory Complex III and IV
(A) Mitochondria from an EV-containing WT strain or an
rcf1D mutant strain expressing Rcf1-His6/HA3 were sub-
jected to two-step purification. The final eluate was
analyzed by silver staining. Discrete bands were excised
and the protein identity was determined by mass spec-
trometry as indicated in the text.
(B) Digitonin-solubilized mitochondria extracted from
yeast strains either expressing Rcf1-His6/HA3 (+) or not ()
were immunoprecipitated using anti-HA antibody. One
percent of the mitochondrial lysate and the final eluate
were immunoblotted using anti-Cor1&Qcr2, Cyt1, Cox1,
Cox2, Cox3, Cox4, and HA antibodies. * indicates IgG light
chain.
(C) Rcf1-His6/HA3 was purified from digitonin and DDM-
solubilized mitochondria, respectively. The final eluate
was visualized by silver stain, and protein identities were
determined by mass spectrometry. Cox3 is indicated
based on SDS-PAGE/western blot because it was not
detected by mass spectrometry.
(D) Mitochondria extracted from a strain harboring
a plasmid expressing Rcf1 or Rcf1-His6/HA3 were solu-
bilized by digitonin or DDM and subjected to BN-PAGE/
western blot. Rcf1, Complex III, and Complex IV were
immunoblotted by anti-HA, Cor1&Qcr 2, and Cox2 anti-
bodies, respectively.
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the whole-cell lysate, but was essentially absent from the post-
mitochondrial supernatant (Figure 1B). The purifiedmitochondria
fraction was subjected to either proteinase K digestion with or
without swelling to rupture the outer membrane (mitoplasts) or
with Triton X-100 to rupture all membranes. Rcf1 was partially
degraded in mitoplasts and was completely degraded upon
Triton X-100 treatment. This pattern is similar to that observed
for Cox2, which is an integral protein of the mitochondrial inner
membrane (Figure 1B). Independently, we found that this same
Rcf1 fusion protein was stably associated with mitochondrial
membranes even following high salt and bicarbonate extraction
(Figure 1C). This is consistent with the bioinformatic prediction
that Rcf1 and its relatives have two transmembrane domains
and are therefore likely to be integral membrane proteins (Fig-
ure S1A available online). Taken together, these results suggest
that Rcf1 is an integral protein of the mitochondrial inner
membrane, as was found for one of the mammalian orthologs
of RCF1 (Wang et al., 2006).
To begin to understand the role of Rcf1 in mitochondrial func-
tion, we generated an rcf1D mutant and subjected it to growth
assays in comparison to a wild-type (WT) strain. The rcf1D350 Cell Metabolism 15, 348–360, March 7, 2012 ª2012 Elsevier Inc.mutant exhibited impaired growth on all nonfer-
mentable carbon sources tested, including
acetate (Figure 1D). This phenotype was exac-
erbated when the experiment was conducted
at 37C (Figure 1D, bottom), consistent with a
destabilization of proteins or protein complexes
in the rcf1D mutant. This slow-growth pheno-
type on nonfermentable carbon sources is
consistent with a partial failure in respiration in
the rcf1Dmutant. To directly assess respiration,we measured oxygen consumption in the WT and rcf1D mutant
strains. The rcf1D mutant had roughly 30% of WT oxygen
consumption on glucose medium and substantial respiratory
defects on lactate and glycerol medium (Figures 1E and S1B).
Together, these results demonstrate that Rcf1 is an integral
protein of the mitochondrial inner membrane that is required
for normal respiratory activity.
Rcf1 Stably Associates with Complex III and Complex IV
of the Electron Transport Chain
To determine the biochemical mechanism that underlies the
role of Rcf1 in mitochondrial respiration, we identified proteins
associated with Rcf1-His6/HA3 expressed at endogenous levels.
After two-step purification, we observed at least nine discrete
bands, which were absent in the empty vector negative control,
in the sample from the Rcf1-His6/HA3 strain (Figure 2A). These
bands primarily contained subunits of either Complex III or
Complex IV from the electron transport chain (Figure 2A and
Table S1). We also observed the ATP/ADP carrier, Aac2, which
was previously shown to associate with electron transport chain
complexes (Dienhart and Stuart, 2008). Bands containing Dld1,
Sdh1, and Jid1 were also observed. Copurification of multiple
Figure 3. Rcf1 Interacts with Complex III and
Complex IV Independently
(A) Rcf1 was immunoprecipitated using anti-HA anti-
bodies from the digitonin-solubilized mitochondria of the
indicated strains harboring either with (+) or without ()
a plasmid expressing Rcf1-His6/HA3. Both 1% crude
lysate and final eluate were immunoblotted using anti-
Cor1&Qcr2, Cyt1, Cox1, Cox2, Cox3, Cox4, HA, and Por1
antibodies, respectively. Asterisk on the anti-Por1 blot
indicates the Cox2 signal from a previous exposure;
arrowhead on the anti-Cox3 blot indicates IgG light chain.
(B) Mitochondria from the indicated strains were analyzed
as in (A).
See also Figure S2.
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confirmed using immunoprecipitation of the Rcf1-His6/HA3
fusion protein (Figure 2B). Note that we observed a clear interac-
tion with Cox3. Perhaps due to its sequence and chemical
properties, Cox3 was not detected by mass spectrometry of
the Rcf1 eluate (Table S1).
It is well known that Complex III and Complex IV physically
associate with one another, forming respiratory supercomplexes
(Scha¨gger and Pfeiffer, 2000; Wittig and Scha¨gger, 2009).
Therefore, it was not surprising that those two complexes
simultaneously copurify with Rcf1. To further explore the interre-
lationships between Rcf1, Complex III, and Complex IV, we
repeated the Rcf1-His6/HA3 purification experiment using both
digitonin-solubilized and dodecylmaltoside (DDM)-solubilized
mitochondria. Although we again observed the same set of
Complex III and Complex IV subunits in the digitonin sample,
the Complex III subunits did not copurify with Rcf1-His6/HA3 in
the DDM-solubilized sample (Figure 2C). Digitonin has been
shown to be mild enough to maintain Complex III/Complex IV
associations in III2/IV and III2/IV2 supercomplexes, whereasCell Metabolism 15,DDM disrupts these interactions. This pattern
of associations in the two detergents was
confirmed by mass spectrometry of the entire
eluate from the purifications. All complex IV
subunits were observed in both digitonin and
DDM, but Complex III subunits were associated
only with Rcf1 in digitonin (Table S1). This
implies that the interaction of Rcf1 with
Complex IV is likely to be more stable than the
interaction with Complex III. Interestingly,
Complex II subunits also were detected in
the Rcf1 eluate, albeit at apparently lower
stoichiometry (Table S1). These observations
were also confirmed using blue native-PAGE
(BN-PAGE) electrophoresis. In DDM-solubilized
mitochondrial lysates, Rcf1-His6/HA3 migrated
in a complex of similar mobility to monomeric
Complex IV, as exemplified by Cox2 (Figure 2D,
lane 3). In digitonin, however, Rcf1-His6/HA3
primarily migrated at the position of the III2/ IV2
heterotetrameric supercomplex (Figure 2D,
lane 4). These data indicate that Rcf1 maintains
strong association with Complex IV in eitherdetergent condition but loses the association with Complex III
in DDM.
This pattern of associations between Rcf1 and the ETC com-
plexes suggested two possibilities. One possible interpretation
is that Rcf1 associates directly with Complex IV and the
copurification with Complex III is indirect, occurring via the
Complex III/Complex IV interaction. The other possibility is that
Rcf1 interacts with both complexes independently, perhaps
even serving as a contact point between the two complexes.
To systematically address this question, we monitored the
association between Rcf1 and Complex III subunits (Cor1,
Qcr2, and Cyt1) and between Rcf1 and Complex IV subunits
(Cox1, Cox2, Cox3, and Cox4) in mutants that lead to the
loss of either Complex III or Complex IV (Figure 3A). The
copurification of Complex IV with Rcf1 in DDM conditions
was recapitulated in this assay. A qcr7D mutant causes severe
failure of Complex III assembly and Rcf1 shows no association
with Cor1 or Qcr2 in this mutant (Figures 3A, lane 11, and 3B,
lane 20), even though both Cor1 and Qcr2 are present in
the mitochondrial lysate (Figures 3A, lane 3, and 3B, lane 10).348–360, March 7, 2012 ª2012 Elsevier Inc. 351
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between Rcf1 and Cyt1, raising the possibility that Rcf1 might
be associated more closely with Cyt1 than Cor1 or Qcr2. As
expected, deletion ofCYT1 also leads to the loss of Rcf1 interac-
tion with Cor1 and Qcr2 (Figure 3A, lane 12). In both of these
mutants, however, the Rcf1 interactions with Cox1, Cox2,
Cox3, and Cox4 were maintained. For Cox1, Cox2, and Cox4,
Rcf1 interactions were compromised but remained significantly
above background. Interestingly, the Rcf1/Cox3 interaction
was not negatively affected by either the qcr7D or cyt1D muta-
tions, suggesting that it might be more proximal to the Rcf1
interaction site than Cox1, Cox2, or Cox4. These data demon-
strate that Rcf1 interacts stably with Complex IV even in the
absence of association with Complex III.
Themore interesting question, however, is whether Rcf1main-
tains an association with Complex III in the absence of Complex
IV. To address this question, we monitored association between
Rcf1 and Complex III subunits in four different mutants lacking
properly assembled Complex IV. They each lead to distinct
defects in the expression, translation, or assembly of different
Complex IV subunits. Deletion of COX11, which encodes
a Cox1 assembly factor, causes impaired synthesis of Cox1
(Barrientos et al., 2004; Horng et al., 2004). Pet494 and Mss51
are translational activators of COX3 and COX1, respectively,
and their deletion causes loss of their respective target (Cos-
tanzo and Fox, 1986; Perez-Martinez et al., 2003). Cox6 is a
Complex IV subunit that might play a role in oxygen sensing
and is indispensible for the stability and activity of Complex IV
(Wright et al., 1995). None of these mutants has intact, properly
assembled Complex IV. In all cases, however, Cor1, Qcr2, and
Cyt1 copurified with Rcf1, albeit at a reduced level compared
to the WT strain (Figure 3A, lanes 13–16). As observed earlier,
we again saw that Cox3 maintained an association with Rcf1
when other Complex IV subunits did not. In spite of this, deple-
tion of Cox3 by mutation of PET494 did not prevent the associ-
ation of Rcf1 with Complex III subunits (Figure 3A, lane 15).
Even after a stringent two-step purification, the same results
were obtained for the WT, qcr7D, and cox11D strains (Figures
S2A and S2B).
The recent publication of higher resolution structures of
respiratory supercomplexes (Althoff et al., 2011; Dudkina et al.,
2011) has provided some insight into the more intimate relation-
ship between Rcf1 and Cox3. These structures show that Cox3,
Cox7, and Cox13 comprise the majority of the interface with
Complex III. As shown above, loss of Cox3 failed to abolish the
ability of Rcf1 to coprecipitate Complex III subunits (Figure 3B,
lane 17). Additionally, neither loss of Cox7 or Cox13 abrogated
the Rcf1/Complex III interaction (Figure 3B, lanes 18 and 19).
Unlike the other Complex IV mutants, the cox13D mutant had
no deleterious effect on the Rcf1 interaction with either Complex
III subunits (Cor1, Qcr2, and Cyt1) or Complex IV subunits (Cox2
and Cox3). Therefore, even the loss of those proteins that are
likely to be most intimately associated with Rcf1 within Complex
IV doesn’t abolish the Rcf1 interactionwith Cor1, Qcr2, andCyt1.
Although it is possible that subcomplexes of Complex IV remain
in any one of these mutants and could mediate the interaction
between Rcf1 and Complex III, it is unlikely that the same sub-
complex bearing that bridging activity is found in each of these
many mutants. We therefore conclude that Rcf1 has the rather352 Cell Metabolism 15, 348–360, March 7, 2012 ª2012 Elsevier Inc.unusual property of interacting directly with components of
Complex III and Complex IV, independent of association with
the other.
Rcf1 Promotes the Stability of Complex III/Complex IV
Supercomplexes
If Rcf1 interacts directly with both Complex III and Complex IV
and, therefore, serves as a point of contact between the two
complexes, it is possible that an rcf1D mutant might exhibit
defects in their association. BN-PAGE analysis was conducted
on theWT and rcf1Dmutant grown in raffinosemedium to induce
mitochondrial biogenesis. As assessed by a-Cor1/Qcr2 immu-
noblot, Complex III migration in the WT strain was almost
completely as the Complex III2/Complex IV2 tetramer (Figure 4A,
left). A small amount of the III2/IV complex was observed, but we
detected no free Complex III. Complex III in the rcf1D mutant,
however, showed a loss of association with Complex IV. There
was a shift from the fully assembled III2/IV2 complex toward
the III2/IV complex and some free III2 dimer was detected.
Examination of Complex IV (Cox3 immunoblot) showed a similar
loss of the III2/IV2 complex and an increase in the III2/IV complex
and free Complex IV in the rcf1D mutant (Figure 4A, middle).
A similar phenotype was observed for the rcf1D mutant in
stationary phase cultures grown in glucose (Figure S3A). Again,
we observed a shift from the fully assembled III2/IV2 complex
toward the III2/IV and III2 complexes. We detected free Complex
IV in the WT strain that was decreased in the rcf1D mutant,
raising the possibility that Complex IV might be less stable to
BN-PAGE analysis under some conditions in the absence of
Rcf1. This appears to not be general, however, because we
observed increased free Complex IV in the rcf1D mutant grown
in raffinose medium (Figure 4A). The migration of Complex V
was unaffected by loss of Rcf1 (Figure S3A). In both raffinose
and glucose cultures, these effects on supercomplex organiza-
tion occurred in the absence of any substantial effect on the
steady-state levels of Complex III or Complex IV subunits
(Figures 4B and S3B). Although the rcf1D mutant may exhibit
a defect in Complex IV assembly or stability, these data strongly
suggest that there is a specific defect in theComplex III/Complex
IV association.
Measurement of complex activity following BN-PAGE was
consistent with these results. As expected, Complex V/ATP syn-
thase exhibited normal activity in the rcf1Dmutant (Figures S3C
and S4C). Total Complex IV activity was decreased in the rcf1D
mutant, and this impairment was due primarily to a loss of activity
in the III2/IV2 complex (Figures S3C and S4C). The loss of
Complex IV activity could be due to an intrinsic defect in
Complex IV or to loss of association with Complex III, which
has been shown to result in Complex IV defects in mammalian
systems (Acı´n-Pe´rez et al., 2008; Gil Borlado et al., 2010). Quan-
titative assays confirmed these results and also showed that
Complex III activity is unaffected by deletion ofRCF1 (Figure 4C).
We also noticed a slight but reproducible defect in the activity of
Complex II in the rcf1D mutant (Figure S3C), possibly indicating
that the interactions between Rcf1 and Complex II subunits
(Table S1) have functional importance.
Rcf1 doesn’t appear to be a stoichiometric constituent of
the Complex III/Complex IV supercomplex. When we immuno-
precipitate Rcf1, we coprecipitate a smaller amount of both
Figure 4. Respiratory Supercomplexes Are
Impaired in the Absence of RCF1
(A) Mitochondria from WT and the rcf1D mutant
grown to log phase in synthetic raffinose medium
were analyzed by BN-PAGE/western blot.
Complex III and Complex IV were immunoblotted
by anti-Cor1&Qcr2 and Cox3 antibodies, respec-
tively. Asterisk indicates the position of free
Complex IV monomer. Porin serves as a control.
(B) The mitochondria from (A) were subjected to
SDS-PAGE and immunoblotted using Cox1,
Cox2, Cox3, Cor1&Qcr2, Cyt1, Rip1, and Sdh2
antibodies. Por1 and Mge1 are loading controls.
(C) Enzymatic activities of Complex III, Complex
IV, and Complex V were measured in lysates of the
WT and rcf1D mutant grown in synthetic raffinose
media to log phase. Each was measured in three
independent cultures and data shown is mean +
SD. *p < 0.05.
(D)Mitochondria from theWT strain with or without
a 2m-based plasmid overexpressing Rcf1 grown
in raffinose medium to log phase were analyzed
by BN-PAGE/Western blot. Complex III, Complex
IV and porin complex were immunoblotted
by anti-Cor1&Qcr2, Cox3 and Por1 antibodies,
respectively.
See also Figure S3.
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Respiratory Supercomplex Assembly FactorComplex III subunits (Cor1, Qcr2, and Cyt1) and Complex IV
subunits (Cox1, Cox2, Cox3, and Cox4) than when we
immunoprecipitate a typical Complex IV subunit, Cox4 (Fig-
ure S3D). Based on that and its apparent function, we
reasoned that overexpression of Rcf1 might increase the
amount of respiratory supercomplexes. As seen in Figure 4D,
expression of Rcf1 from a multicopy 2m plasmid caused
a subtle shift in the Complex IV migration pattern in cells grown
in raffinose. Free Complex IV was lost and both the III2IV and
III2IV2 complexes were increased in abundance, indicating
that increased Rcf1 dosage can promote supercomplex
formation. Although subtle, this effect is reproducible under
distinct growth conditions—stationary phase in glucose
medium (Figure S3E).Cell Metabolism 15, 348–3RCF1 Genetically Interacts with
AAC2 and COX13 to Stabilize
Respiratory Supercomplexes
Two other molecules have been shown
previously to be important for the
assembly of respiratory supercomplexes:
the lipid cardiolipin and the ADP/ATP
translocase Aac2. Loss of either of these
molecules was found to destabilize
supercomplexes (Dienhart and Stuart,
2008; Zhang et al., 2002). We wanted
to examine the genetic relationship
between RCF1, AAC2, and the gene en-
coding cardiolipin synthase CRD1, which
is required for cardiolipin synthesis.
Therefore, we constructed strains lacking
these three genes in all possible combi-
nations and examined their growth under
different conditions. The aac2D strain ex-hibited a complete inability to grow on nonfermentable carbon
sources, making it impossible to use such medium to examine
respiratory growth (Figure S4A). As an alternative, we examined
the survival of these strains in stationary phase, which is also an
indicator of respiratory capability (Gray et al., 2004).When grown
at 30C to log phase, all mutants exhibited normal survival
(Figure 5A, left panel). Even at day 4 of stationary phase, the
three single mutants and the crd1D rcf1D double mutant showed
no loss of viability. However, both of the other double mutants
showed a substantial defect in survival and the triple-mutant
was even more severely affected (Figure 5A, right). When grown
at 37C, the same general pattern was evident, but the syner-
gistic growth defects were more pronounced. These data
demonstrated that loss of the RCF1 and CRD1 genes does not60, March 7, 2012 ª2012 Elsevier Inc. 353
Figure 5. RCF1 Genetically Interacts with AAC2 and COX13 to Stabilize Respiratory Supercomplexes
(A and B) The indicated strains were grown in YPAD media to log or stationary phase as indicated were spotted on YPAD plates and incubated at 30C
(A) or 37C (B).
(C) Mitochondria from the indicated strains grown in raffinose medium to log phase were analyzed by BN-PAGE/western blot. Complex III, Complex IV, and porin
complex were immunoblotted by anti-Cor1&Qcr2, Cox3, and Por1 antibodies, respectively. III2* indicates a Complex III intermediate.
(D) The indicated strains were spotted on SD and SGlycerol/ethanol plates and incubated at 30C. (E) Mitochondria from the indicated strains grown in 1%
glucose medium for 1 day were analyzed by BN-PAGE/western blot. Complex III, Complex IV, and Complex V were immunoblotted by anti-Cor1&Qcr2, Cox2,
and Atp2 antibodies, respectively. III2* indicates a Complex III intermediate.
See also Figure S4.
Cell Metabolism
Respiratory Supercomplex Assembly Factorresult in a synergistic or even an additive phenotype. One
possible explanation is that these two genes act in the same
pathway to promote respiration, a conclusion that is supported
by biochemical data described below. On the other hand, loss
of AAC2 causes a synergistic survival defect with both the
rcf1D and crd1D mutants, a result that is consistent with Aac2
acting in parallel with both Rcf1 and Crd1 to promote supercom-354 Cell Metabolism 15, 348–360, March 7, 2012 ª2012 Elsevier Inc.plex assembly or stability. Both Aac2 and cardiolipin have sig-
nificant roles outside of supercomplex stabilization, which
makes it difficult to draw mechanistic conclusions from genetic
interactions.
To directly assess the assembly and stability of respiratory
supercomplexes in these mutants, we subjected the same
strains to BN-PAGE analysis after growth in raffinose. As
Cell Metabolism
Respiratory Supercomplex Assembly Factorobserved before, the rcf1D mutant showed depletion of the
III2/IV2 complex, as determined both by Complex III and
Complex IV immunoblot (Figure 5C, lanes 2 and 10). The
aac2D mutant exhibited a very similar phenotype (Figure 5C,
lanes 4 and 12). The crd1D single mutant showed a stronger
defect, with an almost complete absence of the III2/IV2 complex
and a significant amount of the III2 and IV species (Figure 5C,
lanes 3 and 11). As seen in the growth assays, the crd1D rcf1D
double mutant showed no additive phenotype and was nearly
identical to the crd1D single mutant (Figure 5C, lanes 5 and
13). The aac2D rcf1D double mutant on the other hand showed
a more substantial loss of the III2/IV2 complex than either single
mutant (Figure 5C, lanes 6 and 14). There was a clear synthetic
phenotype in the aac2D crd1Ddoublemutant, which had a nearly
complete loss of all supercomplexes (Figure 5C, lanes 7 and 15).
Although deletion of AAC2 and CRD1 caused a decrease in the
steady-state levels of some Complex IV subunits, deletion of
RCF1 caused no effect on any Complex III or Complex IV
subunits, even in the context of double mutants that had
a synthetic effect on supercomplex organization (Figure S4B).
Similar phenotypes were also observed in BN-PAGE analysis
of these strains, whichwere grown to stationary phase in glucose
(Figure S4C). Another factor that occupies the predicted inter-
face between Complex III and Complex IV is Cox13. In isolation,
the cox13D mutant exhibits WT growth on both glucose and
glycerol/ethanol plates (Figure 5D). The cox13D rcf1D double
mutant, however, has a more dramatic growth phenotype than
the rcf1D singlemutant when grown under respiratory conditions
(Figure 5D). This growth phenotype is accompanied by a severe
loss of higher-order respiratory supercomplexes, as determined
by BN-PAGE analysis on the strain grown in different conditions.
The cox13D single mutant shows depletion of the III2/IV2
complex similar to that observed in the rcf1Dmutant (Figure 5E).
The cox13D rcf1D double mutant, however, shows almost
a complete loss of the intact III2/IV2 supercomplex and a marked
shift to lower order complexes.
Increased Mitochondrial Oxidative Stress in the rcf1D
Mutant
The physiological importance of mitochondrial ETC supercom-
plexes has not been precisely defined. It has been speculated,
however, that the assembly of individual complexes into super-
complexes enables more efficient electron flow and decreases
the risk of electron stalling. One predicted physiological manifes-
tation of reduced electron stalling would be decreased genera-
tion of reactive oxygen species (ROS) by the ETC. As a means
of assessing the level of oxidative damage in the mitochondrial
matrix of the rcf1D mutant, we measured the activity of aconi-
tase. This mitochondrial enzyme is highly susceptible to inacti-
vation by ROS, due to oxidation of an exposed Fe/S cluster.
Therefore, aconitase activity is a measure of the in vivo burden
of oxidative stress and damage in the mitochondrial matrix (Cris-
cuolo et al., 2005; Gardner et al., 1995). In log phase cultures, we
observed an 20% decrease in aconitase activity in the rcf1D
mutant, compared to an 60% decrease in activity in a mutant
lacking the mitochondrial Mn2+-dependent superoxide dismu-
tase, Sod2 (Figure 6A). In stationary phase cultures, which are
subject to enhanced respiratory activity and elevated oxidative
stress, the aconitase activity was more severely affected inCeboth mutants. We previously showed that overexpression of
RCF1 caused a modest stabilization of higher-order supercom-
plex structures. RCF1 overexpression also caused a nearly
2-fold increase in aconitase activity (Figure 6B). As described
previously, additional loss of COX13 confers a synergistic
growth and supercomplex assembly phenotype upon the rcf1D
mutant strain. The cox13D rcf1D double mutant also exhibited
a more profound loss of aconitase activity relative to either of
the two single mutants (Figure 6C).
We also monitored the susceptibility of WT and mutant strains
to exogenous hydrogen peroxide. Mutants with higher in vivo
production of ROS are typically more sensitive to this exogenous
stress. Compared to WT, the dose-dependent lethality in
response to hydrogen peroxide is exacerbated in the rcf1D
mutant (Figure 6D). In addition, we alsomeasured the expression
of the endogenous ROS defense system, as exemplified by the
mitochondria-specific superoxide dismutase Sod2. The rcf1D
mutant has elevated Sod2 protein levels relative to the WT
control (Figure 6E), which is consistent with this mutant having
elevated endogenous oxidative stress, particularly in mitochon-
dria. We hypothesize that this increased oxidative damage and
sensitivity result from accelerated ROS production by the
electron transport chain. This ETC dysfunction is a predictable
result of impaired assembly of individual complexes into super-
complexes, which promotes reliable, solid-state electron
transmission. As another manifestation of ETC dysfunction, the
rcf1Dmutant exhibited impaired maximal respiration in the pres-
ence of CCCP, which causes dissipation of the mitochondrial
membrane potential and a compensatory acceleration of respi-
ration in WT cells (Figure S5; compare to Figure 1E). The
impaired stimulated respiration in the rcf1Dmutant was accom-
panied by markedly increased sensitivity to CCCP-induced cell
death (Figure 6F).
The HIG2AMammalian Homolog of RCF1 Plays a Role
in Supercomplex Stability
As previously described, our selection ofRCF1 for detailed study
was based partially upon evolutionary conservation among
eukaryotes. We were interested to determine whether the role
we discovered for Rcf1 in supercomplex organization might
also extend to RCF1 orthologs in other species. The mouse
and human genomes contain five homologs of RCF1, which
are subdivided into two classes that are defined by the two
genes with the broadest expression pattern, HIG1A and HIG2A
(Figure S1A). HIG1A was originally described as being strongly
inducible by hypoxia in a HIF-1-dependent manner (Denko
et al., 2000; Kasper and Brindle, 2006). To determine whether
either HIG1A or HIG2A were required for normal supercomplex
assembly or stability in mammalian cells, we transfected cells
with siRNAs targeted to these two genes. Knockdown of
HIG1A (Figure S6B) had no effect on the pattern of supercom-
plex assembly (Figure S6A), which is more complicated in
mammalian cells due to the presence of Complex I and the
stable incorporation of both Complex II and Complex V (Acı´n-
Pe´rez et al., 2008). On the other hand, knockdown ofHIG2A (Fig-
ure 7B) caused a depletion of all higher order supercomplexes
that contain Complex IV, particularly the I+II+III+IV (#3), I+III+IV
(#4), and III+IV (#6) species (Figure 7A) (Acı´n-Pe´rez et al.,
2008). Supercomplex species that do not contain Complex IV,ll Metabolism 15, 348–360, March 7, 2012 ª2012 Elsevier Inc. 355
Figure 6. Increased Mitochondrial Oxidative
Stress in the Absence of RCF1
(A) Cell lysates of the indicated strains grown in SD media
for 0.5 and 2.5 days were subjected to aconitase activity
assay and immunoblotted with anti-Aco1 antibody. Aco-
nitase activity was determined specifically by normalizing
the NADP reduction rate to Aco1 protein-band intensity.
sod2D was used as a control. Mean ± SD of three inde-
pendent cultures is shown. **p < 0.01; ***p < 0.0005.
(B) The WT strain harboring either EV or a 2m-based
plasmid overexpressing Rcf1 were grown for 1 day in 1%
glucose and analyzed as in (A). Mean ± SD of three inde-
pendent cultures is shown. *p < 0.05.
(C) The indicated strains were harvested after being
grown in SD media for 0.5 day and analyzed as in (A).
Mean ± SD of three independent cultures is shown. *, p <
0.05; **p < 0.01.
(D) Log phase cultures (0.5 day) of the WT and rcf1D
mutant were pretreated with H2O2 for 2 hr, spotted on
synthetic glucose medium, and incubated at 30C.
(E) Log phase cultures (0.5 day) of the indicated strains
were harvested and immunoblotted for Sod2, which was
normalized to Por1 intensity. Mean ± SD of six indepen-
dent cultures is shown. **p < 0.01.
(F) WT and the rcf1D mutant strains of the BY4741 back-
ground were grown to log phase in glucose media and an
equal number of cells were plated on media containing
the indicated concentration of CCCP. Number of colonies
was counted after 48 hr. Mean ± SD of three independent
cultures is shown. *p < 0.05.
See also Figure S5.
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fected or slightly increased uponHIG2A depletion (Figure 7A). To
more rigorously evaluate a role for HIG2A and its encoded
protein in supercomplex stability, we generated three additional
siRNAs targeted to HIG2A, two of which caused significant
depletion of the HIG2A mRNA; the other did not (Figure 7D).
The two additional efficacious siRNAs (Si2 and Si3) caused an
identical phenotype to that observed for Si1 (Figure 7C). Specif-
ically, we again observed a loss of supercomplex species con-
taining Complex IV and either unaffected or increased levels of
Complex IV-independent species. At longer exposure of the
anti-Cox1 immunoblot, we also saw a profound depletion of
the #2 I+II+III+IV species in Si2- and Si3-treated cells (Figure 7C,
panel 5). We observed a slight reduction in the amount of free,
fully assembled Complex IV and a slight increase in an incom-
plete Complex IV (IV*). Although these results demonstrate
a role for HIG2A in C2C12 myoblast cells, it is possible that the
four additional mammalian HIG family members serve a related
function in different cell types or different conditions. Deter-
mining their precise roles and contributions in Complex IV and
supercomplex assembly and stability requires additional study.356 Cell Metabolism 15, 348–360, March 7, 2012 ª2012 Elsevier Inc.DISCUSSION
Based on the data presented herein, we
conclude that Rcf1 is a component of respira-
tory supercomplexes and is required for their
normal stability. We also conclude that although
Rcf1 is not essential for basal mitochondrial
function, but is essential for optimally efficientETC function and respiration. Evidence that supports these
conclusions is detailed below.
First, Rcf1 directly interacts with respiratory supercomplexes.
When we purified Rcf1, we copurified stoichiometric amounts
of both Complex III and Complex IV, the major components of
S. cerevisiae ETC supercomplexes. We considered the alterna-
tive explanation that Rcf1 is a previously unidentified component
of Complex IV. The association with Complex III could be indi-
rect, occurring only as a consequence of the interaction between
Complex III and Complex IV. The fact that extraction of mito-
chondria with the relatively harsh detergent DDM causes the
loss of Rcf1/Complex III association could be seen as supporting
this view. However, none of the seven distinct COX mutants
that we have analyzed, six of which exhibit failed assembly of
Complex IV and the destruction of many of its subunits, have
lost the association of Rcf1 with Complex III subunits. Interac-
tions of Rcf1 with Cor1, Qcr2, and Cyc1 are maintained in spite
of the fact that Rcf1 has lost all detectable interaction with
Cox1, Cox2, Cox3, Cox4, and, presumably, other Complex IV
subunits for which we do not have usable antibodies. Similarly,
loss of the Complex III subunit Cyt1 leads to a complete failure
Figure 7. Mammalian HIG2A is Critical
for Normal Respiratory Supercomplex
Organization
(A) Mitochondria extracted from C2C12 cells
transfected with either scrambled (scr) or HIG2A-
targeted siRNA (si1) were solubilized in 2%
digitonin and resolved by BN-PAGE, followed
by immunoblotting with the indicated antibodies.
Respiratory complex species are indicated fol-
lowing the convention of (Acı´n-Pe´rez et al., 2008),
specifically: 1 (I+III+V); 2 (I+II+III+IV); 3 (I+II+III+IV);
4 (I+III+IV); 5 (I+III+V); 6 (III+IV); 7 (III+IV)*.
(B) HIG2A mRNA level normalized to ACTIN
was measured from cells in (A) using quantitative
RT-PCR.
(C) Mitochondria extracted from C2C12 cells
transfected with scrambled (scr) or one of three
unique HIG2A-targeted siRNA (si2, 3, 4) were
treated as in (A). A longer exposure of the anti-
Cox1 immunoblot is shown to enable visualization
of the supercomplexes #1, 2, and 4. Note that si4
is not efficacious in HIG2A knockdown.
(D) HIG2A mRNA level normalized to ACTIN
was measured from cells in (C) using quantitative
RT-PCR.
See also Figure S6.
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Qcr2, although interactions with Complex IV subunits are
maintained.
In general, although mutations impairing either Complex III or
IV assembly do not eliminate the interaction of Rcf1 with the
other Complex, the interactions are significantly weakened.
One exception to this is the Complex IV subunit, Cox3. The
qcr7D and cyt1D (Complex III) mutations eliminate the interac-
tion of Rcf1 with the core Cor1 and Qcr2 subunits of Complex
III. They also greatly impair the Rcf1 interaction with Complex
IV subunits Cox1, Cox4, and, to a lesser extent, Cox2. The
Rcf1 interaction with Cox3, however, is essentially unaffected.
The Rcf1/Cox3 interaction also seems to be unusually persistent
in the face of Complex IV destruction. The cox11D,mss51D, and
cox6D (all Complex IV) mutations each eliminate the interaction
of Rcf1 with Cox1, Cox2, and Cox4, but the interaction with
Cox3 is maintained, albeit at a reduced level. In spite of this
seemingly special relationship between Cox3 and Rcf1, loss of
Pet494, which completely blocks the expression of Cox3, does
not destroy the interaction of Rcf1 with Complex III.
The data demonstrating an intimate association between
Rcf1 and Cox3 has been confusing until recently. If Rcf1 inter-
acts independently with both Complex III and Complex IV,Cell Metabolism 15, 348–3it must occupy a position close to the
interface between them in the respiratory
supercomplex. The structure of the
III2/IV2 supercomplex from S. cerevisiae,
however, suggested that Cox3 was situ-
ated on the face of Complex IV that was
opposite to the Complex III interaction
site (Heinemeyer et al., 2007). This model
was based on low-resolution data, and
the rotational orientation of Complex IVwas quite speculative. Recently, much higher-resolution elec-
tron microscopy reconstructions of the bovine I/III2/IV super-
complex were completed and published (Althoff et al., 2011;
Dudkina et al., 2011). These data clearly show the Complex IV
orientation to be rotated relative to Complex III, placing Cox3
at the site of the Complex III/Complex IV interface. Interestingly,
the docking of the crystal structures of Complex III and Complex
IV into the EMmodel demonstrated a clear gap between the two
complexes, particularly in the juxtamembrane region (Dudkina
et al., 2011). Based on its small size and two transmembrane
domains, this is the region that should be occupied by Rcf1. It
is possible that in addition to cardiolipin, which was postulated
to occupy this position, Rcf1 fills this space and stabilizes the
Complex III/Complex IV interaction.
Second, RCF1 has a robust genetic interaction with AAC2,
which has been implicated previously in stabilizing ETC super-
complexes (Dienhart and Stuart, 2008). In assays of stationary
phase survival, RCF1 and AAC2 exhibited a profound synthetic
phenotype, particularly at elevated temperature. Such a growth
phenotype is potentially due to destabilization of supercom-
plexes, as we showed using blue native-PAGE. AAC2 has
a nearly identical relationship with CRD1, which encodes cardi-
olipin synthase and is necessary for the synthesis of this lipid.60, March 7, 2012 ª2012 Elsevier Inc. 357
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respiratory supercomplexes. There was no additivity, on the
other hand, between RCF1 and CRD1. Although we don’t yet
know how these molecules interrelate in their stabilization of
supercomplexes, these varied genetic interactions imply that
they don’t all function identically or independently.
We also observed a strong genetic interaction between RCF1
and COX13. The Cox13 protein is predicted to occupy the inter-
face between Complex III and Complex IV. Our data shows
amodest loss of the III2/IV2 supercomplexes in the cox13D single
mutant, which is dramatically exacerbated in the cox13D rcf1D
double mutant. This synergistic loss of supercomplexes is
accompanied by a synthetic growth defect and accelerated gen-
eration of oxidative stress, as determined by loss of aconitase
activity. These phenotypes are consistent with the proposed
role of Rcf1 in supercomplex stabilization and with the proposed
role of supercomplexes in prevention of oxidant production.
Finally, loss of Rcf1 leads to a loss of the fully assembled
III2/IV2 supercomplexes and an increase in lower order struc-
tures. The majority of Complex III and IV appears to assume
the III2/IV assemblage but a significant amount of both
complexes dissociate completely from the other. It is important
to note that this effect seems to be specific because assembly
of the other OXPHOS complexes is not impaired. HIG2A, one
of the mammalian homologs of RCF1, appears to play a similar
role in mouse cells. Treatment with any of three siRNAs that
deplete the HIG2A mRNA causes a reduction of all Complex
IV-containing respiratory supercomplexes.
Although we have not explored this possibility to date, it is
likely that the extent and nature of respiratory supercomplexes
is tightly regulated and responsive to environmental conditions.
For example, we predict that nutrient availability, oxygen
concentration, and ATP demand are all likely stimuli for the
adjustment of supercomplex status. This could be accomplished
through transcriptional or posttranscriptional regulation of RCF1
or its homologs in other species. HIG1A, the mouse ortholog of
RCF1whose depletion had no effect on supercomplex organiza-
tion in C2C12 cells, is robustly induced by hypoxia (Denko et al.,
2000). Perhaps HIG1A plays a more prominent role under
hypoxia or in different cells. Indeed, it has been shown to protect
pancreatic b-cells from apoptosis in response to a variety of
stimuli (Wang et al., 2006). Due to its relatively simple supercom-
plex content, S. cerevisiae has only one interaction that can be
targeted for regulation, between Complex III and Complex IV.
In mammals, however, a much more complicated pattern exists.
Complexes I, II, III, IV, and V are all components of respiratory
supercomplexes, and their inclusion and stoichiometry is vari-
able (Acı´n-Pe´rez et al., 2008). The makeup of these complexes
is a likely target of metabolic regulation.
We certainly do not fully understand the consequences of
the loss of supercomplex formation. We do observe, however,
that there is a substantial reduction in respiratory activity, as
measured by total oxygen consumption in the rcf1D mutant.
Perhaps of more interest, it appears that the rcf1D mutant also
has elevated oxidative stress and damage in the mitochondrial
matrix. This was determined by the loss of aconitase activity,
hypersensitivity to exogenous hydrogen peroxide, and an upre-
gulation of the endogenous oxidative stress defenses. These are
common phenotypes among strains that combat an elevated358 Cell Metabolism 15, 348–360, March 7, 2012 ª2012 Elsevier Inc.level of endogenous oxidative stress. One of the factors that
have kept us from an understanding of the effects of supercom-
plex assembly and disassembly is an inability to genetically
manipulate supercomplex formation without disrupting other
mitochondrial functions. As best we can determine, RCF1 dele-
tion causes a specific defect in supercomplex formation in
yeast and HIG2A silencing does the same in mouse cells. These
will be valuable tools in understanding the role and importance
of the assembly of these intricate machines.
EXPERIMENTAL PROCEDURES
Assessment of Submitochondrial Localization
These experiments were performed following a protocol adapted from (Bol-
dogh and Pon, 2007). Mitochondria were incubated in the isotonic SH buffer
or hypertonic H buffer (20 mM HEPES-KOH) with and without 1% Triton
X-100. Protease K was added and incubated on ice for 20–30 min, and diges-
tion was stopped by adding PMSF. Samples were denatured in 6X Laemmli
buffer and resolved by 12% SDS-PAGE, followed by immunoblot. To assess
the solubility of Rcf1, intact mitochondria were extracted by 100 mM
Na2CO3 and 1 M KCl for 20 min on ice. Supernatant was isolated by centri-
fuging samples at 100,000 3 g for 20 min (MLA-130, Beckman Coulter) and
precipitated in 15% TCA. The precipitated supernatant fraction and insoluble
membrane fraction were solubilized in 1X Laemmli buffer, and resolved by
12% SDS-PAGE, followed by immunoblot.
Two-Step Rcf1-His6/HA3 Purification
Crude mitochondria isolated from strains grown in synthetic glycerol/ethanol
medium were solubilized in 0.8% digitonin or dodecylmaltoside (DDM) for
1 hr at 4C. For the first step of the purification, cleared mitochondria lysate
was incubated with equilibrated Ni-NTA beads for 1 hr at 4C. Beads were
washed 5 times with buffer containing 20 mM imidazole. Protein was eluted
by 250 mM imidazole. For the second step of the purification, final eluates of
the first purification were mixed with anti-HA antibody conjugated agarose
(Sigma) for 1 hr at 4C. Agarose was washed 5 times and eluted by 1 mg/ml
HA peptide. Eighty percent of the final precipitate was dissolved in Laemmli
buffer and resolved by SDS-PAGE, followed by silver stain. Protein bands
excised from the gel and the rest of 20% of the final precipitate were analyzed
by mass spectrometry.
Blue-Native Polyacrylamide Gel Electrophoresis (BN-PAGE)
BN-PAGE was performed as described previously (Wittig et al., 2006). Yeast
mitochondria were solubilized in 1% digitonin or DDM and mammalian mito-
chondria were solubilized in 2% digitonin. Lysate was resolved on a 3%–
13% gradient native gel using a PROTEAN II xi Cell gel running system
(Bio-rad). Western blot was performed as the regular procedure using a
Trans-Blot transfer cell (Bio-rad). Membrane was blocked in 5% nonfat
milk/TBS and probed with antibodies as indicated.
Solution ETC Complex Activity Assay
These experiments were performed following a protocol adapted from (Magri
et al., 2010). Ubiqinol:cytochrome c oxidoreductase (Complex III) activity was
determined by measuring the rate of cytochrome c reduction by ubiquinol at
550 nm. Complex III specific activity was calculated by deducing the rate of
cytochrome c reduction of a parallel reaction with antimycin A. Cytochrome
c oxidase (Complex IV) activity was determined by measuring the rate of cyto-
chrome c oxidation. Complex IV-specific activity was verified by adding KCN
into the reaction mixture. ATP synthase (Complex V) activity was determined
by measuring the rate of NADH oxidation. ATP synthase specific activity
was verified by adding oligomycin to stop the reaction. The specific Complex
V activity was calculated by deducing the rate of NADH oxidation in the pres-
ence of oligomycin.
Isolation of Mammalian Mitochondria
The procedure was adapted from (Bozidis et al., 2007). C2C12 cells were
washed twice with PBS, scraped from dishes, and pelleted. Roughly 150 mg
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Respiratory Supercomplex Assembly Factorcell pellet was resuspended in 2 ml of ice-cold MTE buffer. Cells were lysed by
sonication (continuous pulse on power setting of 3.5) 3 times for 10 s each. Cell
debris and nuclei were pelleted at 1,400 3 g for 10 min. Crude mitochondria
were recovered from the supernatant fraction by centrifuging at 10,000 3 g
for 10 min. Mitochondrial pellet was rinsed with MTE and resuspended in it.
Protein concentration was determined by Bradford assay.
Statistics
Data are presented as the means ± standard deviation (SD). Statistical signif-
icance was evaluated by the Student’s t test. *, p < 0.05; **, p < 0.01; ***, p <
0.0005.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Figures S1–S6, and Tables S1 and S2 and can be found with this article online
at doi:10.1016/j.cmet.2012.02.006.
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